>> 全站文章索引 >> 第5页:
  • Neurocognitive Effects of Antipsychotic Medications in Patients With Chronic Schizophrenia in the CATIE Trial - [Keefe RS, Bilder RM, Davis SM, Harvey PD, Palmer BW]
  • Modulation of Attention During Visual Masking in Schizophrenia - [Rassovsky Y, Green MF, Nuechterlein KH, Breitmeyer B, Mintz J]
  • Mental disorders in young and middle aged men who commit suicide - [Isometsä E, Henriksson M, Marttunen M, Heikkinen M, Aro H, Kuoppasalmi K, Lönnqvist J]
  • Premorbid adjustment in schizophrenia — An important aspect of phenotype definition - [Christine Schmael,Alexander Georgia,Bertram Krumm]
  • Working memory dysfunction in schizophrenia compared to healthy controls and patients with depression: Evidence from event-related fMRI - [Henrik Walter,Nenad Vasic,AnnettHöse,Manfred Spitzer,and Robert Christian Wolf]
  • Influence of catechol-O-methyltransferase Val158Met polymorphism on neuropsychological - [Marta Bosia,Margherita Bechi,Elena Marino,Simona Anselmetti]
  • Issues for DSM-V: psychological factors affecting either identified or feared medical conditions: a solution for somatoform disorders - [Fava GA, Wise TN]
  • Is Emotion Processing a Predictor of Functional Outcome in Schizophrenia - [Kee KS, Green MF, Mintz J, Brekke JS]
  • Inadequacy of antidepressant treatment for patients with major depression who are at risk for suicidal behavior - [Oquendo MA, Malone KM, Ellis SP, Sackeim HA, Mann JJ]
  • Implications for the Neural Basis of Social Cognition for the Study of Schizophrenia - [Amy E. Pinkham, B.S., David L. Penn, Ph.D., Diana O. Perkins, M.D. and Jeffrey Lieberman, M.D]
  • Hysteria split asunder - [Hyler SE, Spitzer RL]
  • Hyperammonemia Due to Valproic Acid in the Psychiatric Setting - [Carr RB, Shrewsbury K]
  • Hyperammonemia and Coma Developed by a Woman Treated With Valproic Acid for Affective Disorder - [Emmanuel Eze, M.D., Marc Workman, M.D. and Brian Donley, M.S.]
  • Effective adjunctive use of tandospirone with perospirone for enhancing verbal memory and quality of life in schizophrenia - [Tomiki Sumiyoshi,Yuko Higuchi, Mie Matsui,Hirofumi Arai]
  • Cerebral glucose utilization and platelet mitochondrial complex I activity in schizophrenia: A FDG-PET study - [Dorit Ben-Shachara,Omer Bonne, Roland Chisin, Ehud Klein]
  • Episodic memory and neuroimaging of hippocampus and fornix in chronic schizophrenia - [Paul G. Nestor,Marek Kubicki, Noriomi Kuroki, Ronald J. Gurrera]
  • Brain activation mediates the association between structural abnormality and symptom severity in schizophrenia - [Sara Weinsteina,Todd S. Woodward,and Elton T.C. Ngan]
  • FDA Alert on Antidepressants for Youth - [Mitka M]
  • Familiality of Polarity at Illness Onset in Bipolar Affective Disorder - [Kassem L, Lopez V, Hedeker D, Steele J, Zandi P]
  • Early psychosocial intervention following traumatic events - [Bisson JI, Brayne M, Ochberg FM, Everly GS Jr]
  • Early cognitive-behavioural therapy for post-traumatic stress symptoms after physical injury. Randomised controlled trial - [Bisson JI, Shepherd JP, Joy D, Probert R, Newcombe RG]
  • Cognition, drug treatment, and functional outcome in schizophrenia: a tale of two transitions - [Green MF]
  • Disrupted in Schizophrenia 1 Genotype and Positive Symptoms in Schizophrenia - [Pamela DeRossea,Colin A. Hodgkinson, Todd Lencz, Katherine E. Burdicka]
  • Prepulse Inhibition and P50 Suppression Are Both Deficient but not Correlated in Schizophrenia Patients - [David L.Braff,Gregory A.Light,and Neal R.Swerdlow]
  • Three-Dimensional Laser Surface Imaging and Geometric Morphometrics Resolve Frontonasal Dysmorphology in Schizophrenia - [Robin J. Hennessy, Patrizia A. Baldwin, David J. Browne]
  • Stress and coping responses to a natural disaster in people with schizophrenia - [William P. Horana,Joseph Venturaa, Jim Mintza, Alex Kopelowicz]
  • Startle gating in antipsychotic-naïve first episode schizophrenia patients One ear is better than two - [Veena Kumari,Dominic Fannon,Alexander L.Sumich,Tonmoy Sharma]
  • Effect of olanzapine or risperidone treatment on some cognitive functions in a one-year follow-up of schizophrenia - [Manuel Gurpegui,Enrique Álvarez,Manuel Bousoño]
  • Bilateral disadvantage: Lack of interhemispheric cooperation in schizophrenia - [Kylie J.Barnett,Ian J.Kirk,Michael C.Corballis]
  • Substance abuse and schizophrenia: Pharmacotherapeutic intervention - [AlanI.Green,(M.D.),Douglas L.Noordsy,(M.D.),Mary F.Brunette,(M.D.),Christopher O’Keefe,(M.S.)]
  • Minocycline a second-generation tetracycline as a neuroprotective agent in an animal model of schizophrenia - [Yechiel Levkovitz,Uri Levi,Yoram Braw,Hagit Cohen]
  • Clinical Utility as a Criterion for Revising Psychiatric Diagnoses - [Michael B. First, M.D., Harold Alan Pincus, M.D., John B. Levine, M.D]
  • Individual psychotherapy in the outpatient treatment of adults with anorexia nervosa - [P Hay, J Bacaltchuk, A Claudino, D Ben-Tovim, PY Yong]
  • Interventions for obsessive compulsive symptoms in people with schizophrenia - [M Raj, S Farooq]
  • Mortality among persons with schizophrenia in Sweden: An epidemiological study - [Björn Milesson Fors 1; Dag Isacson 2; Kerstin Bingefors 2; Birgitta Widerlöv]
  • Anxiety symptoms in schizophrenia spectrum disorders: associations with social function, positive and negative symptoms, hope and trauma history - [P. H. Lysaker,M. P. Salyers]
  • Immune variations in bipolar disorder: phasic differences - [Abigail Ortiz-Domíngueza, María Eugenia Hernándezb, Carlos Berlangaa, Doris Gutiérrez-Moraa, Julia M]
  • Adult and peer involvement in help-seeking for depression in adolescent population : A two-year follow-up in Finland - [Sari Fröjd1, Mauri Marttunen,Mirjami Pelkonen]
  • Augmentation strategies for treatment-resistant depression a literature review - [A. F. Carvalho* MD PhD, J. L. Cavalcante† MD, M. S. Castelo* MD MSc, M. C. O. Lima* MD PhD]
  • Comorbidity of Pediatric Obsessive-Compulsive Disorder and Anxiety Disorders Impact on Symptom Severity and Impairment - [Eric A. Storch, Michael J. Larson, Lisa J. Merlo1, Mary L. Keeley]
  • Is social anxiety disorder in childhood associated with developmental deficit/delay? - [Hanne Kristensen1 and Svenn Torgersen]
  • Differences between prepubertal- versus adolescent- onset bipolar disorder in a Spanish clinical sample - [Luisa Lázaro,Josefina Castro-Fornieles, José Eugenio de la Fuente]
  • Bipolar disorder and panic disorder in families an analysis of chromosome 18 data - [MacKinnon DF, Xu J, McMahon FJ, Simpson SG, Stine OC, McInnis MG, DePaulo JR]
  • Association between antidepressant prescribing and suicide in Australia - [Hall WD, Mant A, Mitchell PB, Rendle VA, Hickie IB, McManus P]
  • Antidepressants and the Risk of Suicidal Behaviors - [Hershel Jick, MD; James A. Kaye, MD, DrPH; Susan S. Jick, DSc]
  • Antidepressants and Suicidal Behavior Cause or Cure - [David Brent, M.D.]
  • Treating acute stress disorder: an evaluation of cognitive behavior therapy and supportive counseling techniques - [Bryant RA, Sackville T, Dang ST, Moulds M, Guthrie R]
  • A prospective study of heart rate response following trauma and the subsequent development of posttraumatic stress disorder - [Shalev AY, Sahar T, Freedman S, Peri T, Glick N, Brandes D, Orr SP, Pitman RK]
  • Columbia Classification Algorithm of Suicide Assessment (C-CASA) - [Posner K, Oquendo MA, Gould M, Stanley B, Davies M]
  • A single 20 mg dose of dihydrexidine (DAR-0100), a full dopamine D1 agonist, is safe and tolerated in patients with schizophrenia - [Mark S.Georgea,Christine E.Molnar,Emily L.Grenesko,Berry Anderson]
  • Reduced N-acetyl-aspartate levels in schizophrenia patients with a younger onset age: A single-voxel 1H spectroscopy study - [Jeffrey A.Stanley,Madhuri Vemulapalli,Jeffrey Nutche,Debra M. Montrose,John A.Sweeney]
  • Anterior cingulate volumes in schizophrenia: A systematic review and a meta-analysis of MRI studies - [M. Baiano,A.David,A.Versace,R.Churchill,M.Balestrieri and P. Brambilla]
  • Refining the Predictive Pursuit Endophenotype in Schizophrenia - [L.Elliot Hong,Kathleen A.Turano,Hugh O]
  • Why does the worldwide prevalence of childhood attention deficit hyperactivity disorder matter? - [Moffitt TE, Melchior M]
  • Two-year prevalence and stability of individual DSM-IV criteria for schizotypal - [McGlashan TH, Grilo CM, Sanislow CA, Ralevski E, Morey LC, Gunderson JG, Skodol AE]
  • Trends in the Prescribing of Psychotropic Medications to Preschoolers - [Zito JM, Safer DJ, dosReis S, Gardner JF, Boles M, Lynch F]
  • Treatment of Psychiatric Symptoms Associated With a Frontal Lobe Tumor Through Surgical Resection - [Hoffer ZS, Allen SL, Mathews M]
  • Treatment of borderline personality disorder with psychoanalytically oriented partial hospitalization: an 18-month follow-up - [Bateman A, Fonagy P]
  • A preliminary study of emotion processing interference in schizophrenia and schizoaffective disorder - [Laura K.Phillips,Martina M.Voglmaier,Patricia J.Deldin]
  • Stability of functional language lateralization over time in schizophrenia patients - [Annick Razafimandimby,Olivier Maïza,Pierre-Yves Hervé]
  • Association analysis of polymorphisms in the N-methyl-d-aspartate (NMDA) receptor subunit 2B (GRIN2B) gene and tardive dyskinesia in schizophrenia - [Ying-Jay Liou,Ying-Chieh Wang,Jen-Yeu Chen,Ya-Mei Bai]
  • The regional prefrontal syndromes a theoretical and clinical overview - [Duffy JD, Campbell JJ 3rd]
  • The Place of Psychoanalytic Treatments Within Psychiatry - [Gabbard GO, Gunderson JG, Fonagy P]
  • The long-term course of rapid-cycling bipolar disorder - [Coryell W, Solomon D, Turvey C, Keller M, Leon AC, Endicott J, Schettler P, Judd L, Mueller T]
  • The homocysteine hypothesis of depression - [Folstein M, Liu T, Peter I, Buell J, Arsenault L, Scott T, Qiu WW]
  • The Food and Drug Administration’s Deliberations on Antidepressant Use in Pediatric Patients - [Leslie LK, Newman TB, Chesney PJ, Perrin JM]
  • The FDA pediatric advisories and changes in diagnosis and treatment of pediatric depression - [Pfeffer CR]
  • The extent of drug therapy for attention deficit-hyperactivity disorder among children in public schools - [LeFever GB, Dawson KV, Morrow AL]
  • The emerging role of neuroimaging in psychiatry: characterizing treatment-relevant endophenotypes - [Phillips ML]
  • Sympathoadrenal Hyperactivity and the Etiology of Neuroleptic Malignant Syndrome - [Gurrera RJ]
  • Neurological soft signs and minor physical anomalies in patients with schizophrenia and related disorders - [Michael T.Compton,Annie M.Bollini,LaTasha McKenzie Mack,Aimee D.Kryda]
  • Premorbid behavioral and intellectual functioning in schizophrenia patients with poor response to treatment with antipsychotic drugs - [Asaf Caspi,Abraham Reichenberg,Mark Weiser,Jonathan Rabinowitz]
  • Switching from 'unipolar' to bipolar II. An 11-year prospective study of clinical and temperamental predictors in 559 patients - [Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell W, Keller M, Warshaw M, Clayton P, Goodwin F]
  • Suicidality in pediatric patients treated with antidepressant drugs - [Hammad TA, Laughren T, Racoosin J]
  • Schizophrenia and cognitive dysmetria: a positron-emission tomography study of dysfunctional prefrontal-thalamic-cerebellar circuitry - [Andreasen NC, O]
  • Risk for bipolar illness in patients initially hospitalized for unipolar depression - [Goldberg JF, Harrow M, Whiteside JE]
  • Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 surveys' estimates - [Narrow WE, Rae DS, Robins LN, Regier DA]
  • Researchers probe depression in children - [Voelker R]
  • Relation of neurological soft signs to psychiatric symptoms in schizophrenia - [Vijay A.Mittal,Wendy Hasenkamp,Michael Sanfilipo,Susan Wieland]
  • Functional polymorphisms of the cytochrome P450 1A2 (CYP1A2) gene and prolonged QTc interval in schizophrenia - [Joshua K.X.Tay,Chay Hoon Tan,Siow-Ann Chongc,Ene-Choo Tan]
  • Insight, distress and coping styles in schizophrenia - [Michael Cooke,EmmanuellePeters,Dominic Fannon,Anantha P.P.Anilkumar]
  • Plasma homocysteine, folate and B12 in chronic schizophrenia - [Alexandros Haidemenos,Dimitrios Kontis,1,Anthia Gazi,Eleni Kallai,Matthew Allin,Boniatsi Lucia]
  • Relationship between antidepressant medication treatment and suicide in adolescents - [Olfson M, Shaffer D, Marcus SC, Greenberg T]
  • Recovery from major depression in older adults receiving augmentation of antidepressant pharmacotherapy - [Dew MA, Whyte EM, Lenze EJ, Houck PR, Mulsant BH, Pollock BG, Stack JA, Bensasi S]
  • Recent life events, cortisol, dehydroepiandrosterone and the onset of major depression in high-risk adolescents - [Goodyer IM, Herbert J, Tamplin A, Altham PM]
  • Recent developments in understanding the psychosocial aspects of depression - [Harris T]
  • Psychotropic practice patterns for youth: a 10-year perspective - [Zito JM, Safer DJ, DosReis S, Gardner JF, Magder L, Soeken K, Boles M, Lynch F, Riddle MA]
  • Psychotropic Drug Use in Very Young Children - [Joseph T. Coyle, MD]
  • Prevalence of large cavum septi pellucidi and its relation to the medial temporal lobe structures in schizophrenia spectrum - [Tsutomu Takahashi,Michio Suzuki,Hirofumi Hagino,Lisha Niu,Shi-Yu Zhou]
  • Positive family history is associated with persistent elevated emotional distress in schizophrenia: Evidence from a 16-month follow-up study - [Michael S.Ritsner,Yael Ratner,Anatoly Gibel,Ronit Weizman]
  • Oxidative–antioxidative systems and their relation with serum S100 B levels in patients with schizophrenia: Effects of short term antipsychotic treatment - [Asli Sarandol,Selcuk Kirli,Cengiz Akkaya,Aysun Altin,Meral Demirci,Emre Sarandol]
  • Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder - [Zito JM, Safer DJ, dosReis S, Magder LS, Gardner JF, Zarin DA]
  • Psychopharmacology for Young Children: Clinical Needs and Research Opportunities - [Benedetto Vitiello]
  • Primary care role in the management of childhood depression: a comparison of pediatricians and family physicians - [Rushton JL, Clark SJ, Freed GL]
  • Relationship of auditory verbal hallucinations with cerebral asymmetry in patients with schizophrenia: An event-related fMRI study - [Zhijun Zhang,Jiabo Shi,Yonggui Yuan,Guifeng Hao,Zhijian Yao,Ning Chen]
  • A comprehensive assessment of gray and white matter volumes and their relationship to outcome and severity in schizophrenia - [Serge A.Mitelman,Adam M.Brickman,Lina Shihabuddin,Randall E.Newmark]
  • Reduction in event-related alpha attenuation during performance of an auditory oddball task in schizophrenia - [Masato Higashima,Takahiro Tsukada,Tatsuya Nagasawa,Takashi Oka,Takeshi Okamoto]
  • Prospective memory deficits in subjects with schizophrenia spectrum disorders - [Ya Wang,Raymond C.K.Chan,Xin Yu,Chuan Shi,Jifang Cui,Yongyu Deng]
  • Processing spatial–temporal information in recent-onset schizophrenia: The study of short-term memory and its susceptibility to distraction - [Caroline Cellard,Se´bastien Tremblay,Catherine Lehoux,Marc-Andre´ Roy]
  • Gender differences in response to antipsychotic treatment in outpatients with schizophrenia - [Judith Usall,David Suarez,Josep Maria Haro]


    • 分页: 1 2 3 4 [5] 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40
    41 42 43 44 45 46 47 48 49 50